Cargando…

Safety of Lubiprostone in Pediatric Patients With Functional Constipation: A Nonrandomized, Open-Label Trial

OBJECTIVES: Pediatric functional constipation (PFC) affects up to 30% of children. Current treatments often do not sustain symptomatic relief. Lubiprostone is a locally acting chloride channel activator that promotes fluid secretion into the small bowel without affecting serum electrolyte concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussain, Sunny Z., Labrum, Barrett, Mareya, Shadreck, Stripling, Stephen, Clifford, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Articles: Gastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528133/ https://www.ncbi.nlm.nih.gov/pubmed/34387619 http://dx.doi.org/10.1097/MPG.0000000000003280

Ejemplares similares

Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation
por: Adams, Atoya, et al.
Publicado: (2021)

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation
por: Chang, L., et al.
Publicado: (2016)

Lubiprostone: a novel treatment for chronic constipation
por: Lacy, Brian E, et al.
Publicado: (2008)

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation
por: Pennington, Becky, et al.
Publicado: (2018)

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly
por: Gras-Miralles, Beatriz, et al.
Publicado: (2013)

Lubiprostone for the Treatment of Adult Women with Irritable Bowel Syndrome with Constipation
por: Soubra, Mahmoud, et al.
Publicado: (2012)

Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders
por: Cryer, Byron, et al.
Publicado: (2017)

Lubiprostone for the Treatment of Clozapine-Induced Constipation: A Case Series
por: Torrico, Tyler J, et al.
Publicado: (2022)

Factors associated with long-term efficacy of lubiprostone for chronic constipation
por: Morise, Takashi, et al.
Publicado: (2023)

Effectiveness and safety of lubiprostone after switching from stimulant laxatives in elderly patients with chronic constipation
por: Maruyama, Masaki, et al.
Publicado: (2023)

Rectosigmoid Adenocarcinoma Presenting As Nine Days of Constipation
por: Thota, Sri Sai Prasanna, et al.
Publicado: (2023)

Prevalence of suspected child abuse in children with constipation: a case–control study
por: Vriesman, Mana H, et al.
Publicado: (2022)

Efficacy and Safety of Sofosbuvir-Velpatasvir combination in Hepatitis C Virus-infected Pakistani Patients without Cirrhosis or with Compensated Cirrhosis: A Prospective, Open-label Interventional Trial
por: Butt, Nazish, et al.
Publicado: (2020)

Efficacy and safety of inulin supplementation for functional constipation: a systematic review protocol
por: Liu, Xinyuan, et al.
Publicado: (2021)

A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
por: Cryer, Byron, et al.
Publicado: (2014)

Effects of Lubiprostone, an Intestinal Secretagogue, on Electrolyte Homeostasis in Chronic Idiopathic and Opioid-induced Constipation
por: Rao, Satish S.C., et al.
Publicado: (2021)

Characteristics of the Contrast Enema Do Not Predict an Effective Bowel Management Regimen for Patients with Constipation or Fecal Incontinence
por: Huber, Jordan, et al.
Publicado: (2016)

Poor Sleep Quality as a Risk Factor for Constipation Among Community-Dwelling Older Adults in Japan
por: Nakagawa, Hiroaki, et al.
Publicado: (2023)

Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome
por: Lunsford, Tisha N, et al.
Publicado: (2010)

A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain
por: Jamal, M Mazen, et al.
Publicado: (2015)

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
por: Nag, Arpita, et al.
Publicado: (2020)

Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation
por: Lembo, Anthony J., et al.
Publicado: (2011)

The Safety of Minimally Invasive and Open Cholecystectomy in Elderly Patients With Acute Cholecystitis: A Systematic Review
por: Montenegro, Diana M, et al.
Publicado: (2022)

Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes
por: Hayat, Maham, et al.
Publicado: (2019)

Faecal Incontinence and Constipation
por: McFarlane, X A, et al.
Publicado: (1997)

Stimulation of Mucin, Mucus, and Viscosity during Lubiprostone in Patients with Chronic Constipation may Potentially Lead to Increase of Lubrication
por: Majewski, Marek, et al.
Publicado: (2014)

Effect of Lubiprostone on Urinary Protein Excretion: A Report of Two IgA Nephropathy Patients with Chronic Constipation
por: Takeshita, Mitsuhide, et al.
Publicado: (2019)

Role of Lubiprostone on Gastrointestinal Motility
por: Jun, Jae Yeoul
Publicado: (2013)

Acupuncture for functional constipation: protocol of an individual patient data meta-analysis
por: Zheng, Qianhua, et al.
Publicado: (2015)

Clubbed Digits Presumably Caused by Lubiprostone
por: Kawamoto, Ryuichi, et al.
Publicado: (2021)

Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation
por: Tanaka, Kosuke, et al.
Publicado: (2022)

Evaluating the Safety and Quality of Diagnostic Colonoscopies Performed by General Surgeons: A Retrospective Study
por: Naeem, Muhammad Saulat, et al.
Publicado: (2023)

Different doses of prucalopride in treating chronic idiopathic constipation: a meta-analysis and Bayesian analysis
por: Yang, Tao, et al.
Publicado: (2021)

An open-label pilot trial of faecal microbiome transfer to restore the gut microbiome in anorexia nervosa: protocol
por: Wilson, Brooke C, et al.
Publicado: (2023)

Safety of Endoscopy and Its Outcome in Pregnancy
por: Kamani, Lubna, et al.
Publicado: (2019)

Comparison Between Closed and Open Methods for Creating Pneumoperitoneum in Laparoscopic Cholecystectomy
por: Agarwal, Puneet K, et al.
Publicado: (2023)

An Unusual Presentation of Primary Hepatic Diffuse Large B-cell Lymphoma of the Liver
por: Dhingra, Rohit, et al.
Publicado: (2018)

A Prospective, Nonrandomized, Open‐Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis
por: Glaser, Dee Anna, et al.
Publicado: (2015)

Laparoscopic Versus Open Rectopexy for Rectal Prolapse: A Randomized Controlled Trial
por: Mohapatra, Kailash Chandra, et al.
Publicado: (2021)

Laparoscopic Cholecystectomy Versus Open Cholecystectomy in Acute Cholecystitis: A Literature Review
por: Mannam, Raam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_85t8oti40f1ns4hkd2cs33umhg